GÜLTEKİN, M. Et Al. 2020. In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. RADIOTHERAPY AND ONCOLOGY , vol.147 , 232.

GÜLTEKİN, M., TİLKİ, B., & YILDIZ, F., (2020). In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. RADIOTHERAPY AND ONCOLOGY , vol.147, 232.

GÜLTEKİN, MELİS, BURAK TİLKİ, And FERAH YILDIZ. "In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial," RADIOTHERAPY AND ONCOLOGY , vol.147, 232, 2020

GÜLTEKİN, MELİS Et Al. "In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial." RADIOTHERAPY AND ONCOLOGY , vol.147, pp.232, 2020

GÜLTEKİN, M. TİLKİ, B. And YILDIZ, F. (2020) . "In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial." RADIOTHERAPY AND ONCOLOGY , vol.147, p.232.

@article{article, author={MELİS GÜLTEKİN Et Al. }, title={In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial}, journal={RADIOTHERAPY AND ONCOLOGY}, year=2020, pages={232} }